BHF | Ticker Profile - Titan Protect

BHF

Brighthouse Financial, Inc.

Financial Services · Insurance - Life · NMS

$62.65

Data: 2026-05-28

✗ ETHICAL FAIL

Unknown MOAT

HIGH

Data Confidence: 85.7%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$3.6B

Total market value of the company

Trailing P/E

N/A

Forward P/E

3.21

Based on estimated future earnings — lower means cheaper

Rev Growth

-36.2%

Year-over-year revenue change

Profit Margin

-1.1%

How much profit the company keeps from each dollar of revenue

ROE

-1.1%

Return on equity — how efficiently it uses shareholder money

Analyst Target

$66.00

+5% from current price — median analyst estimate

Recommendation

HOLD

Consensus view from 6 analysts covering this stock

About Brighthouse Financial, Inc.

Brighthouse Financial, Inc. provides annuity and life insurance products in the United States. The company operates through Annuities, Life, and Run-off segments. The Annuities segment offers variable, fixed, index-linked, and income annuities for contract holders' needs for protected wealth accumulation on a tax-deferred basis, wealth transfer, and income security. The Life segment provides term, universal, whole, and variable life products for policyholders' needs for financial security and protected wealth transfer. The Run-off segment manages universal life with secondary guarantees, structured settlements, pension risk transfer contracts, various company-owned life insurance policies, and funding agreements. Brighthouse Financial, Inc. was founded in 1863 and is headquartered in Charlotte, North Carolina.

https://www.brighthousefinancial.com

Country: United States Employees: 1,400 Industry: Insurance - Life

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

FAIL

Core business does not involve prohibited activities

Debt Ratio

0.0% N/A

Debt must be below 33% of total assets

Cash Ratio

0.0% N/A

Interest-bearing cash below 33% of assets

Receivables

0.0% N/A

Receivables below 49% of assets

Revenue Purity

0.0% N/A

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

ACCUMULATION

Smart money appears to be building positions quietly

Sharpe Ratio

0.635

Good returns relative to risk taken

Kelly Fraction

0.0631

Suggested allocation is meaningful — the edge justifies a position

Calmar Ratio

0.707

Acceptable balance between returns and drawdown risk

Annual Return

22.0%

Historical annualised return based on price data

Max Drawdown

-31.1%

Largest peak-to-trough decline — the worst it has been

HMM State

SIDEWAYS

Price consolidating — no clear directional bias

Days in State

118

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

0.88

Less volatile than the market — more defensive

52W High

$66.33

6% below the year high

52W Low

$42.07

49% above the year low

Avg Volume

597,336

Average daily shares traded — higher means easier to buy and sell

Short Ratio

13.7

Days it would take all short sellers to cover — higher means more crowded

Short % Float

13.2%

Elevated short interest — bears are positioned against this

Div Yield

N/A

Annual dividend as a percentage of the share price

EPS (TTM)

$-3.07

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

176.33

Heavy leverage — higher financial risk if revenues decline

Current Ratio

1.54

Healthy liquidity position

Quick Ratio

1.15

Like current ratio but excludes inventory — stricter test

Gross Margin

25.6%

Revenue left after cost of goods — higher means pricing power

Operating Margin

-63.4%

Profit from core operations before interest and tax

Free Cash Flow

$-524,124,992

Negative — the business is spending more than it generates

Revenue (TTM)

$6.1B

Total revenue over the last 12 months

Net Income

$-167,000,000

Loss-making — spending exceeds revenue after all costs

Analyst Coverage

Analysts

Target High

$70.00

Target Median

$66.00

Target Low

$55.00

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-28

Before you go